Caroline Roan is vice president of corporate responsibility at Pfizer and the president of the Pfizer Foundation. During her tenure, Pfizer has refined its strategy to better address today's highly complex global health challenges. The resulting portfolio is a coordinated approach to strategic philanthropy and responsible investment, which invests the full scope of the company's resources to broaden access to medicines and strengthen health care delivery for underserved people around the world.
Thanks to an expansive global partnership and donation program, Pfizer believes the global elimination of trachoma can be achieved. How did the global community make such dramatic progress against trachoma in so short a time? And why is it so important for the 163 million individuals still at risk of this neglected tropical disease that we finish the job? Pfizer's Caroline Roan and Dr. Edridah Muheki Tukahebwa of Uganda's Ministry of Health explain.
What’s in store for the future of health care markets and financing in the developing world? In this guest column, Caroline Roan — Pfizer Foundation president and Pfizer Inc. vice president for corporate responsibility — looks at the road ahead, exploring how donors, implementers, and private sector partners can leverage their strengths to continue to increase market access.